University of Michigan
2,002
252
342
1,369
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
10.2%
205 terminated/withdrawn out of 2002 trials
87.0%
+0.5% vs industry average
8%
158 trials in Phase 3/4
38%
525 of 1369 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (2002)
Brain-computer Interface Commercial Readiness
Role: collaborator
Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
Role: lead
Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease
Role: collaborator
Michigan Weight Navigation Program (MiWeigh) Study
Role: lead
Emotional Awareness and Expression Therapy for Chronic Pain and Opioid Use Disorder
Role: lead
Evaluation of a Telehealth Case Management Intervention to Prevent Suicide Among Soldiers Discharged From Psychiatric Hospitalization
Role: collaborator
Mechanism of SGLT2 Inhibition in the Kidney
Role: lead
Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation
Role: lead
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
Role: collaborator
SHARE Program: SUSTAIN
Role: collaborator
Tele-video to Improve Daily Activity 2.0
Role: lead
Nephrotic Syndrome Study Network
Role: lead
A Study Comparing Two Types of Supportive Interventions for Caregivers of Patients With Cancer
Role: collaborator
NEPTUNE Match Study
Role: lead
Neurobehavioral Signatures of Sign- and Goal-Tracking in Emerging Adults: Translation of a Preclinical Model
Role: lead
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
Role: collaborator
WeCare: A System of Care for Black Youth
Role: collaborator
Postpartum Intervention for Mothers With Opioid Use Disorders (R33)
Role: collaborator
Health Coaching: A Pilot Trial Among Reintegrating Veterans
Role: collaborator
Characterization and Analysis of Evoked Cortical Responses in Participants With Medication-intractable Epilepsy
Role: lead